The Female Health Company (AMEX: FHC), the sole manufacturer and marketer of the FC1 and FC2 female condoms, provides an innovative option to women that protects against both sexually transmitted diseases and unintended pregnancy. The Company holds exclusive product and technology patents for FC1 in the United States, Australia, Brazil, Canada, France, Germany, Italy, Spain, the United Kingdom, the People’s Republic of China, South Korea and Japan, while patents are pending for FC2. For further information, visit the Company’s web site at www.femalehealth.com.
- 18 years ago
QualityStocks
The Female Health Company (AMEX: FHC)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) to Attend SOF Week 2026
This article has been disseminated on behalf of SPARC AI Inc. and may include paid…
-
QualityStocksNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Appoints VP Exploration And VP Mining Operations
This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.…
-
QualityStocksNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Initiates First Commercial Manufacturing Order For Preservative-Free Ketamine
NRx Pharmaceuticals (NASDAQ: NRXP) announced it has initiated its first commercial manufacturing order of preservative-free…